Lipoprotein apheresis: a Hellenic consensus on its clinical use-Reference-Cited by-同舟云学术

Lipoprotein apheresis: a Hellenic consensus on its clinical use

Published:2021-11 Issue:6 Volume:62 Page:460-462
ISSN:1109-9666
Container-title:Hellenic Journal of Cardiology
language:en
Short-container-title:Hellenic Journal of Cardiology

Author:

Kolovou Genovefa^ORCID,Kolovou Vana,Bilianou Helen,Goumas Georgios,Foussas Stefanos,Grapsa Eirini,Garoufi Anastasia,Karavolias Georgios^ORCID,Mavrogieni Sophie^ORCID,Melidonis Andreas,Milionis Haralampos,Rallidis Loukianos,Richter Dimitris,Skoumas Ioannis,Tousoulis Dimitris,Vlachopoulos Charalambos,Liberopoulos Evangelos^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2019

2. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia;Kolovou;Eur J Prev Cardiol,2020

3. Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia;Wang;J Am Heart Assoc,2016

4. The German lipoprotein apheresis registry (GLAR) - almost 5 years on;Schettler;Clin Res Cardiol Suppl,2017

5. Alirocumab in patients with heterozygous fa- milial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial;Moriarty;Eur Heart J,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications;Pharmaceuticals;2023-05-16

2. Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia;Journal of Clinical Medicine;2022-02-13